Announced by Novo Nordisk on May 2, 2025, the investigational oral formulation of semaglutide is targeted for chronic weight management in patients with obesity or overweight and 1 comorbid condition and to reduce the risk of major adverse cardiovascular events (MACE) in those with overweight or obesity and established cardiovascular disease
When you eventually reach your goal weight, or when you and your provider decide to transition to a GLP-1 maintenance dose , the skills you develop during stalls, adjusting protein, maintaining exercise, managing sleep, monitoring hydration, and tolerating the scale not moving, are exactly the skills you will need for long-term weight maintenance
Why Weight and Drinking Often Go Together Before understanding why one drug can address both issues, it helps to understand why weight and alcohol problems so often coexist
PlexusDx offers this as an optional add-on ($298), supporting a more informed provider conversation about expected response variability and individualized treatment planning
Learn the difference between NAD+ and B12 injections, their benefits, and which one is best for boosting energy, metabolism, and recovery
Everyday Treatment for Keratosis Pilaris Because keratosis pilaris results from this build-up, its important to exfoliate the skin effectively and consistently